Search Results - "Murata, Rumi"

Refine Results
  1. 1
  2. 2

    Clinical outcomes of stereotactic body radiotherapy for stage I non-small cell lung cancer using different doses depending on tumor size by Baba, Fumiya, Shibamoto, Yuta, Ogino, Hiroyuki, Murata, Rumi, Sugie, Chikao, Iwata, Hiromitsu, Otsuka, Shinya, Kosaki, Katsura, Nagai, Aiko, Murai, Taro, Miyakawa, Akifumi

    Published in Radiation oncology (London, England) (17-09-2010)
    “…The treatment schedules for stereotactic body radiotherapy (SBRT) for lung cancer vary from institution to institution. Several reports have indicated that…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    Chemoradiotherapy for localized extranodal natural killer/T-cell lymphoma, nasal type, using a shrinking-field radiation strategy: multi-institutional experience by Hattori, Yukiko, Murai, Taro, Iwata, Hiromitsu, Uchiyama, Kaoru, Mimura, Mikio, Kato, Eriko, Murata, Rumi, Shibamoto, Yuta

    Published in Japanese journal of radiology (01-04-2016)
    “…Purposes The prognosis of localized extranodal natural killer/T-cell lymphoma, nasal type (ENKTL), has improved with the development of chemoradiotherapy…”
    Get full text
    Journal Article
  6. 6

    Interaction between combretastatin A-4 disodium phosphate and radiation in murine tumors by Murata, Rumi, Siemann, Dietmar W., Overgaard, Jens, Horsman, Michael R.

    Published in Radiotherapy and oncology (01-08-2001)
    “…Background and purpose: The ability of combretastatin A-4 disodium phosphate (CA4DP) to induce vascular damage and enhance the radiation response of murine…”
    Get full text
    Journal Article
  7. 7
  8. 8

    An antiangiogenic agent (TNP-470) inhibited reoxygenation during fractionated radiotherapy of murine mammary carcinoma by Murata, R, Nishimura, Y, Hiraoka, M

    “…TNP-470, a synthetic analogue of fumagillin which is a natural product of Aspergillus fumigatus, has been noted as an angiogenesis inhibitor. Combined effects…”
    Get more information
    Journal Article
  9. 9

    Combining Vascular Targeting Agents with Radiation: An Effective Anti-Tumor Treatment but Associated with Radiation-Induced Systemic Toxicity by Nomura, Miwako, Murata, Rumi, Brøndum, Line, Ehrnrooth, Eva, Sørensen, Brita S., Horsman, Michael R.

    “…This study investigated the effect of combining radiation with an angiogenesis inhibitor and vascular disrupting agent on tumor response and systemic toxicity…”
    Get full text
    Journal Article
  10. 10

    Intensity-modulated radiation therapy using static ports of tomotherapy (TomoDirect): comparison with the TomoHelical mode by Murai, Taro, Shibamoto, Yuta, Manabe, Yoshihiko, Murata, Rumi, Sugie, Chikao, Hayashi, Akihiro, Ito, Hiroya, Miyoshi, Yoshihito

    Published in Radiation oncology (London, England) (21-03-2013)
    “…With the new mode of Tomotherapy, irradiation can be delivered using static ports of the TomoDirect mode. The purpose of this study was to evaluate the…”
    Get full text
    Journal Article
  11. 11

    Optical isomers of a new 2-nitroimidazole nucleoside analog (PR-350 series): radiosensitization efficiency and toxicity by Oya, N, Shibamoto, Y, Sasai, K, Shibata, T, Murata, R, Takagi, T, Iwai, H, Suzuki, T, Abe, M

    “…A new 2-nitroimidazole nucleoside radiosensitizer, PR-350 (1-[1',3',4'-trihydroxy-2'-butoxy]-methyl-2-nitroimidazole), has been reported to be as efficient as…”
    Get more information
    Journal Article
  12. 12

    Transcatheter arterial infusion therapy in the treatment of advanced pancreatic cancer: A feasibility study by SHIBUYA, K, NAGATA, Y, ITOH, T, OKAJIMA, K, MURATA, R, TAKAGI, T, HIRAOKA, M

    “…To evaluate the effects of transcatheter arterial infusion (TAI) therapy in 18 patients with advanced pancreatic cancer. The drugs infused were epirubicin 60…”
    Get full text
    Journal Article
  13. 13

    Enhanced local tumour control after single or fractionated radiation treatment using the hypoxic cell radiosensitizer doranidazole by Murata, Rumi, Tsujitani, Michihiko, Horsman, Michael R

    Published in Radiotherapy and oncology (01-06-2008)
    “…Abstract Objective This study was designed to assess the potential of the nitroaromatic radiosensitizer doranidazole to preferentially enhance…”
    Get full text
    Journal Article
  14. 14

    Changes in Cell Proliferative Parameters of SCCVII and EMT6 Murine Tumors after Single‐dose Irradiation by Murata, Rumi, Nishimura, Yasumasa, Shibamoto, Yuta, Hiraoka, Masahiro, Abe, Mitsuyuki

    Published in Japanese Journal of Cancer Research (01-06-1996)
    “…To understand better the repopulation kinetics of tumor cells after radiotherapy, we Investigated changes in cell proliferative parameters after single‐dose…”
    Get full text
    Journal Article
  15. 15

    Intensity modulated stereotactic body radiation therapy for single or multiple vertebral metastases with spinal cord compression by Murai, Taro, Murata, Rumi, Manabe, Yoshihiko, Sugie, Chikao, Tamura, Takeshi, Ito, Hiroya, Miyoshi, Yoshihito, Shibamoto, Yuta

    Published in Practical Radiation Oncology (01-11-2014)
    “…The purpose of this study was to evaluate the efficacy and toxicity of intensity modulated radiation therapy with simultaneous integrated boost (SIB-IMRT) for…”
    Get full text
    Journal Article
  16. 16

    Reoxygenation in the SCCVII tumor after KU-2285 sensitization plus single or fractionated irradiation by Shibamoto, Y, Kitakabu, Y, Murata, R, Oya, N, Shibata, T, Sasai, K, Takahashi, M, Abe, M

    “…Because reoxygenation of solid tumors after irradiation with a hypoxic cell sensitizer has never previously been investigated, we assessed the reoxygenation in…”
    Get more information
    Journal Article
  17. 17

    Vascular targeting effects of ZD6126 in a C3H mouse mammary carcinoma and the enhancement of radiation response by Horsman, Michael R, Murata, Rumi

    “…The aim of this study was to investigate the pathophysiologic effects induced by the novel vascular targeting agent ZD6126 in a C3H mouse mammary carcinoma and…”
    Get more information
    Journal Article
  18. 18

    Comparison of in vivo Efficacy of Hypoxic Cytotoxin Tirapazamine and Hypoxic Cell Radiosensitizer KU‐2285 in Combination with Single and Fractionated Irradiation by Shibata, Toru, Shibamoto, Yuta, Sasai, Keisuke, Oya, Natsuo, Murata, Rumi, Takagi, Takehisa, Hiraoka, Masahiro, Abe, Mitsuyuki

    Published in Japanese Journal of Cancer Research (01-01-1996)
    “…Development of strategies to eradicate radioresistant hypoxic cells would be of great benefit for clinical radiotherapy. In the present study, the in vivo…”
    Get full text
    Journal Article
  19. 19

    Combination of vascular targeting agents with thermal or radiation therapy by Horsman, Michael R, Murata, Rumi

    “…The most likely clinical application of vascular targeting agents (VTAs) is in combination with more conventional therapies. In this study, we report on…”
    Get more information
    Journal Article
  20. 20

    Comparison of radiosensitizing effect of KU-2285 and SR-2508 at low drug concentrations and doses by Shibata, T, Shibamoto, Y, Oya, N, Sasai, K, Murata, R, Ishigaki, T, Abe, M

    “…Since the radiosensitizing effect of KU-2285 at relatively low dose levels is not known, we investigated its efficacy at such low concentrations or doses…”
    Get more information
    Journal Article